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OBJECTIVE: The aim of the present study was to investigate the relationship between pericoronary fat and the
severity and extent of atherosclerosis, quantified using 64-multidetector computed tomography, in patients
with suspected coronary artery disease.
METHODS: The study population consisted of 131 patients who were clinically referred for noninvasive
multislice computed tomography coronary angiography for the evaluation of coronary artery disease. Patients
were classified as follows: no atherosclerosis, Group 1; nonobstructive atherosclerosis (luminal narrowing,50%
in diameter), Group 2; and obstructive atherosclerosis (luminal narrowing $50%) in a single vessel or
obstructive atherosclerosis in the left main coronary artery and/or multiple vessels, Group 3. Epicardial adipose
tissue was defined as the adipose tissue between the surface of the heart and the visceral layer of the
pericardium (visceral epicardium). Epicardial adipose tissue thickness (mm) was determined in the right
ventricular anterior free wall. The mean thickness of the pericoronary fat surrounding the three coronary
arteries was used for the analyses.
RESULTS: The average thickness over all three regions was 13.2 ¡ 2.1 mm. The pericoronary fat thickness was
significantly increased in Group 3 compared with Groups 2 and 1. The epicardial adipose tissue thickness was
significantly increased in Group 3 compared with Groups 2 and 1. A receiver operating characteristic curve for
obstructive coronary artery disease was assessed to verify the optimum cut-off point for pericoronary fat
thickness, which was 13.8 mm. A receiver operating characteristic curve for obstructive coronary artery disease
was also assessed to verify the optimum cut-off point for epicardial adipose tissue, which was 6.8 cm.
CONCLUSION: We showed that the epicardial adipose tissue and pericoronary fat thickness scores were higher
in patients with obstructive coronary artery diseases.
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Visceral adipose tissue is an important indicator of
cardiovascular risk (1). Abdominal obesity has been shown
to be a stronger predictor of cardiovascular risk than
increased body mass index (2). Abdominal adipose tissue
is able to produce large quantities of tumor necrosis factor-
alpha, interleukin-6, free fatty acids, and plasminogen
activator inhibitor-1, which are involved in accelerated
atherosclerosis, plaque instability, and arterial thrombosis
(3-5).
Adipose tissue surrounding the coronary arteries, often
called epicardial adipose tissue (EAT), may also act as an
endocrine organ due to their comparable patterns of
adipocytokine production (6,7). Evidence is accumulating
that EAT may be linked to the development of coronary
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atherosclerosis through several paracrine mechanisms, such
as local inflammatory mediators that trigger the athero-
sclerotic process, and other systemic effects (8).
Previous studies have demonstrated an association
between EAT and the presence and extent of coronary
artery disease (CAD). The association between EAT thick-
ness and CAD has been previously evaluated using
echocardiography. However, computed tomography (CT)
is more accurate in quantifying adipose tissue accumulation
due to its higher spatial resolution. The aim of the present
study was to investigate the relationship between pericor-
onary fat and the severity and extent of atherosclerosis,
quantified using 64-multidetector CT, in patients with
suspected CAD.
& METHODS
The study population consisted of 131 patients who were
clinically referred for noninvasive multislice computed
tomography (MSCT) coronary angiography for CAD eva-
luation. The exclusion criteria for MSCT coronary angio-
graphy were a history of percutaneous coronary interven-
tion, previous coronary artery by-pass surgery, or known
cardiomyopathy. End-stage renal disease, liver failure, and
triglyceride levels .400 mg/dl were also exclusion criteria
for the study. The study protocol was approved by our
internal institutional review board.
Demographic data were collected on all patients through
a retrospective chart review. Height and weight measured
at the time of imaging were used to calculate body mass
index (BMI). Hypertension was defined as a systolic blood
pressure $14 mmHg and/or a diastolic blood pressure
$90 mmHg or current antihypertensive treatment. Dyslipi-
demia was defined as total cholesterol $200 mg/dl, low-
density lipoprotein (LDL) cholesterol $130 mg/dl, high-
density lipoprotein (HDL) cholesterol ,30 mg/dl, or
current lipid-modifying agent treatment. Diabetes mellitus
was defined as a fasting glucose $126 mg/dl or current
hypoglycemic treatment. Smoking was classified as current
smoking if the patient smoked or quit within the last 30 days
and not smoking if the patient never smoked or smoked in
the remote past.
Patients were classified as follows: no atherosclerosis,
Group 1 (n = 36); nonobstructive atherosclerosis (luminal
narrowing ,50% in diameter), Group 2 (n= 42); and
obstructive atherosclerosis (luminal narrowing $50%) in a
single vessel or obstructive atherosclerosis in the left main
coronary artery and/or multiple vessels, Group 3 (n= 53).
EAT and pericoronary fat were quantified using electro-
cardiogram (ECG)-gated diagnostic cardiac CT scans. CT
studies were performed on a 64 detector-row CT scanner
(Brilliance 64, Philips Medical Systems, Cleveland, OH,
USA). The scan duration time was 7-10 s, and the average
heart rate during image acquisition was 58¡9 beats/min.
Standard coronary imaging protocols were applied, includ-
ing the use of intra-venous beta blockers for patients with
heart rates .65 beats/min (unless contraindicated), and
image acquisitions were performed during an inspiratory
breath-hold. The imaging parameters were a slice collima-
tion of 64 mm60.625 mm, gantry rotation time of 420 ms,
tube voltage of 120 kV, and tube current of 900 mA. The
contrast agent used was iopromide (Schering AG, Berlin,
Germany), which was injected intravenously (1.6-2.0 g
iodine/s depending on the patient’s body weight).
Measurements were performed in the most motionless
phase of the cardiac cycle, which was most frequently the
mid-diastolic phase, with retrospective cardiac gating at
70-80% of the R-R interval. The window settings were
adjusted to enable adequate visualization of the adipose
tissue and the pericardium (Figure 1). Coronary artery
calcification (CAC) was quantified based on the Agatston
score, which is a measure of the area of a calcified lesion
multiplied by a factor based on the maximum pixel density.
The computer system provided the Agatston score for each
of the following locations: left main coronary artery, left
anterior descending artery, circumflex artery, right coronary
artery, aortic annulus and root, ascending aortic wall, and
mitral annulus. A total score representing the cumulative
calcium burden in all of the above locations was then
calculated for each patient as the final Agatston score, which
is reported in the results. EAT was defined as the adipose
tissue between the surface of the heart and the visceral layer
of the pericardium (visceral epicardium). EAT thickness
(mm) was measured on the right ventricular (RV) anterior
free wall. Measurements were performed at the base (basal
level) of the ventricles on short-axis views of a regular
Philips CT workstation. The basal level was defined as the
level at the base of the ventricles. Three measurements of
EAT thickness were made, namely, inferior, center, and
Figure 1 - A) Epicardial fat thickness (yellow arrows). B) Pericoronary fat thickness (green). LV= left ventricle; RCA= right coronary
artery; RV= right ventricle.
CLINICS 2014;69(6):388-392 Pericoronary Fat Thickness Computed Tomography
Demircelik MB et al.
389
superior, corresponding to measurements at the 25%, 50%
and 75% level of the RV wall, respectively, from the visceral
epicardium to the outside of the myocardium and perpen-
dicular to the surface of the heart. The mean of the three
measurements (referred to as ‘EAT’) was used for the
analyses. Pericoronary fat was defined as the adipose tissue
between the surface of the heart and the visceral epicardium
directly surrounding the main coronary arteries.
Pericoronary fat thickness (mm) was quantified on axial
views of a regular Philips CT workstation. To avoid
overestimating the pericoronary fat due to obliquity,
thickness measurements were performed on images in
which the axial sections were perpendicular to the surface
of the heart. In each of the regions of the right coronary
artery (RCA), left coronary artery (LCA), and left circumflex
(LCX), the maximum fat thickness, assessed as the largest
distance from the myocardium to the visceral epicardium,
was determined. The mean thickness of the pericoronary fat
surrounding the three coronary arteries was used to analyze
the pericoronary fat thicknesses (PCFT).
Statistical analysis of the data was performed using SPSS
(Statistical Package for Social Science, Inc., Chicago, Illinois,
EUA) for Windows 11.5. Whether the continuous variables
were normally distributedwas investigated using the Shapiro-
Wilk test. Descriptive statistics were expressed as the mean¡
standard deviation for continuous variables and as the
number of cases and percentage for categorical variables.
The difference between groups with respect to normally
distributed continuous variables was analyzed by analysis of
variance (ANOVA), and the significance of the difference
between non-normally distributed continuous variables was
analyzedwith theMann-Whitney U test. Categorical variables
were evaluated with Pearson’s chi-square or Fisher’s exact
test. The significance of the linear correlation between the
three groups and EAT and PCFT measurements was
evaluated with Spearman’s correlation analysis. A p value of
, 0.05 was considered statistically significant.
& RESULTS
The patient demographics and clinical characteristics are
shown in Table 1. There was no significant difference
between the 3 groups except for smoking and diabetes
status. The incidences of smoking and diabetes were
significantly higher in Group 3. Patients were divided into
3 groups, and the subjects in all groups were predominantly
male. The mean age of the study population was 54 ¡ 11
years. CAC was significantly higher in Group 3. The
average thickness of the layer of PCFT surrounding the
coronary arteries was 15.5¡ 3.3 mm (range 6.9-37.6 mm) in
the RCA area, 6.2¡ 2.0 mm (range 1.9-15.0 mm) in the LAD
area, and 11.8 ¡ 3.4 mm (range 2.6-30.1 mm) in the LCX
area. The average thickness over all three regions was
13.2¡ 2.1 mm. PCFT was significantly increased in Group 3
compared with Groups 2 and 1 (R= -0.240, R= -0.233, R =
-0.283) (Tables 2-3). No obstructive CAD was present in 36
patients (27%), whereas non-obstructive atherosclerotic
CAD and obstructive atherosclerosis were present in
42 (32%) and 53 (41%) patients, respectively. The EAT
thickness was significantly increased in Group 3 compared
with Groups 2 and 1 (7.1¡ 2.7 cm, 4.7¡ 1.9 cm and 3.2¡
1.1 cm, respectively, and R= -0.438, R= -0.328, and R=
-0.447, respectively) (Figure 2 and Tables 2-3).
A ROC curve for OCAD was assessed to verify the
optimum cut-off point for PCFT, which was 13.8 mm. The
area under the curve (AUC) for PCFT was 71.4% (95%
confidence interval [CI], 0.665-0.764), with a sensitivity of
72.2% and a specificity of 68.1%. A ROC curve for OCAD
was assessed to verify the optimum cut-off point for EAT,
which was 6.8 cm. The AUC for PCFT was 71.5% (95%CI,
0.750-0.777), with a sensitivity of 73.5% and a specificity of
69.3% (Figure 3).
Thus, the results demonstrate that the EAT and PCFT
scores were higher in patients with obstructive coronary
artery diseases.
& DISCUSSION
The major finding of this population-based study was that
EAT directly surrounding the coronary arteries is related to
obstructive atherosclerosis in patients. Our study showed
that EAT and PCFT were particularly high in the high-risk
group (diabetics and patients with high CAC scores).
Previous studies on EAT thickness were mainly based on
echocardiography and measured EAT thickness in the right








Ages (years) 52 ¡ 10 51¡ 8 56 ¡ 12 NS
Gender (male %) 63 61 67 NS
Urea (mg/dl) 32 ¡ 8 30 ¡ 8 31 ¡ 9 NS
Creatinine (mg/dl) 0.8 ¡ 0.5 0.9 ¡ 0.3 0.7 ¡ 0.6 NS
FPG (mg/dl) 93 ¡ 30 94 ¡ 27 94 ¡ 23 NS
Total cholesterol (mg/dl) 200 ¡ 45 210 ¡ 43 207 ¡ 41 NS
LDL cholesterol (mg/dl) 125 ¡ 38 123 ¡ 35 127 ¡ 42 NS
HDL cholesterol (mg/dl) 45 ¡ 12 44 ¡ 11 40 ¡ 10 NS
Triglycerides (mg/dl) 155 ¡ 73 150 ¡ 65 157 ¡ 67 NS
Body mass index (kg/m2) 24.2 ¡ 3.1 24.6 ¡ 3.0 25 ¡ 3.2 NS
Diabetes Mellitus % 14.5 15.3 22.1 0.023
Hypertension % 39.1 35 41 NS
Current smoking % 41.2 42 49 0.033
CAC score 38 ¡ 25 305 ¡ 129 640 ¡ 301 , 0.01
CAC: Coronary artery calcium.
Table 2 - EAT and PCFT measurements according to
group.
Group 1 Group 2 Group 3
EAT (cm) thickness 3.2 ¡ 1.1 4.7 ¡ 1.9 7.1 ¡ 2.7
PCFT (mm) 10.9 ¡ 1.7 14.0 ¡ 1.3 16.3 ¡ 2.1
EAT: Epicardial adipose tissue
PCFT: Pericoronary fat tissue
Group 1: No atherosclerosis
Group 2: Nonobstructive atherosclerosis (luminal narrowing ,50% in
diameter)
Group 3: Obstructive atherosclerosis (luminal narrowing$50%) in a single
vessel or obstructive atherosclerosis in the left main coronary artery and/
or multiple vessels.
Table 3 - EAT and PCFT measurement correlation analysis
between the groups.
GROUP 1 GROUP 2 GROUP 3
EAT (cm) thickness R= -0.438 R= -0.443 R= -0.447
PCFT (mm) R= -0.420 R= -0.453 R= -0.445
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ventricle only or in the combined epicardial and pericardial
adipose tissue surrounding the heart (1,9-12). Differen-
tiation between epi- and pericardial fat may be difficult with
echocardiographic examination (13). On CT, the pericar-
dium is readily identified, resulting in easy differentiation
between epi- and pericardial fat. In contrast to previous
studies, we focused on the epicardial fat surrounding the
arteries because of the notion that it is the local fat that may
drive the development of atherosclerosis. Multislice CT
provides an accurate and reproducible quantification of
EAT due to its high temporal and spatial resolution. Ahn
et al. (14) studied the association between the thickness of
EAT on the free wall of the RV and CAD in patients who
underwent conventional coronary angiography due to chest
pain. A positive association was found between EAT
thickness and the presence of significant coronary stenosis
(luminal narrowing -50%) and with the number of coronary
arteries with significant stenosis. In contrast, a study by
Chaowalit et al. (15) in 139 patients who were referred for
conventional coronary angiography did not show a sig-
nificant correlation between EAT thickness and number of
atherosclerotic coronary segments.
In our study, we found a positive correlation between not
only EAT but also PCFT and the number of diseased vessels
and calcified lesions. Previous studies evaluating the
relationship between EAT and angiographic CAD have
yielded conflicting results, most likely due to differences in
the measurement techniques and study populations (16-18).
A positive correlation was shown between EAT thickness
and CAD severity. In our present study, we showed that
EAT and PCFT could be predictors of coronary athero-
sclerosis. MSCT can be used to provide an estimate of the
severity of EAT and PCFT. In line with previous findings
(19), the amount of EAT and pericoronary fat was strongly
associated with obesity in patients with suspected CAD.
Adipose tissue is a major driver of insulin resistance, an
Figure 2 - EAT and PCFT in the three groups.
Figure 3 - A) ROC curve for PCFT for the development of obstructive coronary artery disease (OCAD). A ROC curve for OCADwas plotted
to verify the optimum cut-off point for PCFT, which was 13.8 mm. The AUC for PCFT was 71.4% (95%CI, 0.665-0.764), with a sensitivity
of 72.2% and a specificity of 68.1%. B) ROC curve for EAT for the development of OCAD. A ROC curve for OCAD was plotted to verify
the optimum cut-off point for EAT, which was 6.8 cm. The AUC for PCFT was 71.5% (95%CI, 0.750-0.777), with a sensitivity of 73.5%
and a specificity of 69.3%.
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essential pathophysiological feature associated with the
development of metabolic disorders, including hyperglyce-
mia, hypertension, and low HDL cholesterol (2,20). In our
study, LDL cholesterol levels did not differ between the two
groups. This result demonstrates the importance of EAT
and PCFT, as they could be risk factors independent of the
level of LDL cholesterol.
Several limitations of our study should be considered.
The present study was performed in a heterogeneous study
population. The present analysis was restricted to an
evaluation of the association between coronary athero-
sclerosis and EAT thickness. The proatherogenic process,
which relates EAT and predisposition to atherosclerosis,
was not investigated.
In conclusion, EAT and PCFT are related to severe
coronary atherosclerosis. MDCT may be an invaluable
diagnostic tool with which to determine EAT and PCF
thickness.
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